MedTrace Logo

Telephone-Based Acceptance and Commitment Therapy for Young Adult Hazardous Drinkers

NCT07621822 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2026-08-17

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if telephone-based Acceptance and Commitment Therapy (ACT) works to help young adults with hazardous or harmful alcohol use quit drinking. It will also learn about the psychological effects of ACT on participants.

The main questions it aims to answer are:

1. Does telephone-based ACT increase the number of participants who quit drinking, as confirmed by a urine test?
2. Does telephone-based ACT help participants reduce their alcohol consumption and improve their psychological flexibility?

Researchers will compare telephone-based ACT to a telephone-based social support programme to see if ACT works to help young adults quit drinking.

Participants will:

1. Receive telephone-based ACT or social support once a week for 6 weeks Complete questionnaires about their alcohol use and psychological flexibility.
2. Keep a record of their daily alcohol consumption throughout the study using a standardised diary method.
3. Provide a urine sample at the 6-month follow-up if they report having quit drinking

Conditions

  • Hazardous Drinking
  • Harmful Alcohol Use

Interventions

BEHAVIORAL

Telephone-Based Acceptance and Commitment Therapy (ACT)

Participants in the intervention group will receive six weekly telephone sessions of ACT (45-60 min each) from interventionist.

BEHAVIORAL

Waitlist control with Telephone-Based Social Support

Participants in the control group will receive six weekly telephone sessions of social support (45 min each) from interventionist.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2029-07-31
Completion
2029-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07621822 on ClinicalTrials.gov